Physician profile
Jack Robert Thurman
NPI 1063091676
$713.67
in general payments reported to CMS, 2019-2025
11 companies · $670 in 2025
The $670 reported for 2025 was more than what 81% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $43.64 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $213.25 | 2025 | Flexitouch Plus, Nimbl |
| Astrazeneca Pharmaceuticals LP | $88.48 | 2025 | Breztri |
| Amgen INC. | $77.87 | 2025 | Repatha |
| Kerecis Limited | $77.33 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Shockwave Medical, INC | $61.25 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $43.64 | 2024 | Exparel |
| Stryker Corporation | $40.58 | 2025 | Flowtriever |
| Integra Lifesciences Corporation | $37.25 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Solventum Corporation | $27.60 | 2025 | V.A.C.Ulta, Prevena, V.A.C. Veraflo Cleanse Choice |
| Boston Scientific Corporation | $23.40 | 2025 | Eluvia |
| Medtronic, INC. | $23.02 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Thurman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.